Cleared Special

K231553 - OverStitch NXT Endoscopic Suturing System (FDA 510(k) Clearance)

Jun 2023
Decision
30d
Days
Class 2
Risk

K231553 is an FDA 510(k) clearance for the OverStitch NXT Endoscopic Suturing System. This device is classified as a Endoscopic Tissue Approximation Device (Class II - Special Controls, product code OCW).

Submitted by Apollo Endosurgery, Inc. (Austin, US). The FDA issued a Cleared decision on June 29, 2023, 30 days after receiving the submission on May 30, 2023.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 876.1500. To Aid In Endoscopically Placing Sutures, Staples, Clips, And Other Fastening Tools Through Tissue..

Submission Details

510(k) Number K231553 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 30, 2023
Decision Date June 29, 2023
Days to Decision 30 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code OCW - Endoscopic Tissue Approximation Device
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.1500
Definition To Aid In Endoscopically Placing Sutures, Staples, Clips, And Other Fastening Tools Through Tissue.